PTPA and allergic asthma: PP2A activators like 2-amino-4-(4-(heptyloxy) phenyl)-2-75 methylbutan-1-ol (AAL(S)) inhibit inflammation and AHR in allergic asthma, reducing eosinophil infiltration, mucus-secreting cells, Th2 cytokines, and serum IgE levels.